Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Estrella Immunopharma, Inc.
Market Cap
$18.87M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.41M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.72M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.98M
Net Profit Margin
-33.08%
TTM Avg
-29.53%
3Y Avg
-30.32%
5Y Avg
-22.32%
Market Cap
$17.76M
Net Profit Margin
-706.23%
TTM Avg
-81.41%
3Y Avg
-315.86%
5Y Avg
-1797.64%
Market Cap
$17.07M
Net Profit Margin
-755.13%
TTM Avg
-243.50%
3Y Avg
-516.28%
5Y Avg
-344.84%
Market Cap
$16.86M
Net Profit Margin
-219.50%
TTM Avg
-381.91%
3Y Avg
-332.62%
5Y Avg
-409.39%
Market Cap
$16.55M
Net Profit Margin
-106.58%
TTM Avg
-228.29%
3Y Avg
-394.31%
5Y Avg
-410.59%
Market Cap
$22.43M
Net Profit Margin
-24.76%
TTM Avg
-22.59%
3Y Avg
-21.34%
5Y Avg
-47.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $18.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.41M | 0.00% | 0.00% | 0.00% | 0.00% |
| Modular Medical, Inc. (MODD)vs › | $19.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $18.98M | -33.08% | -29.53% | -30.32% | -22.32% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.76M | -706.23% | -81.41% | -315.86% | -1797.64% |
| Lipocine Inc. (LPCN)vs › | $17.07M | -755.13% | -243.50% | -516.28% | -344.84% |
| Dyadic International, Inc. (DYAI)vs › | $16.86M | -219.50% | -381.91% | -332.62% | -409.39% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.55M | -106.58% | -228.29% | -394.31% | -410.59% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | -24.76% | -22.59% | -21.34% | -47.79% |
| BioCardia, Inc. (BCDA)vs › | $16.08M | 0.00% | -6850.00% | -4251.62% | -4766.26% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-02-28 | 0.00% |
